Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aram... Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. Mostrar mais
Pergunte à ADVFN Intelligence (IA)
| Período | Var | Var % | Abe | Máx. | Mín. | Vol Méd. | VWAP diário | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.75 | -30.5944055944 | 5.72 | 5.79 | 3.82 | 210184 | 4.41119751 | CS |
| 4 | 0.43 | 12.1468926554 | 3.54 | 23.8 | 3.34 | 8157699 | 12.39964629 | CS |
| 12 | 0.388 | 10.8319374651 | 3.582 | 23.8 | 2.73 | 3170697 | 11.41730979 | CS |
| 26 | -0.83 | -17.2916666667 | 4.8 | 23.8 | 2.73 | 1520799 | 11.25010153 | CS |
| 52 | -1.7 | -29.9823633157 | 5.67 | 23.8 | 2.73 | 857039 | 10.5067218 | CS |
| 156 | -494.63 | -99.2037705576 | 498.6 | 563.4 | 2.73 | 382584 | 40.97163872 | CS |
| 260 | -716.03 | -99.4486111111 | 720 | 1328.4 | 2.73 | 299109 | 201.12185807 | CS |
Suporte: (11) 4950 5808 | suporte@advfn.com.br
Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições
Recursos principais
Premium
